Short-term holding room treatment of asthmatic children

Insights

Holding room treatment for childhood asthma is effective, with most children discharged within 24 hours. This approach is medically sound and significantly more cost-effective than hospitalization for pediatric asthma emergencies.

Area of Science:

  • Pediatric Emergency Medicine
  • Respiratory Medicine
  • Health Economics

Background:

  • Childhood status asthmaticus is a common pediatric emergency.
  • Hospitalization is the traditional management approach, often involving prolonged intravenous therapy.
  • Alternative, cost-effective treatment strategies are needed.

Purpose of the Study:

  • To compare the efficacy and cost-effectiveness of holding room treatment versus hospitalization for pediatric status asthmaticus.
  • To evaluate recurrence rates and treatment costs associated with each management strategy.

Main Methods:

  • A randomized trial involving 51 patients treated in a holding room and 52 hospitalized patients.
  • Data collection included length of stay, intravenous therapy duration, and 28-day recurrence rates.
  • Cost analysis compared holding room treatment versus hospitalization.

Main Results:

  • Two-thirds of patients in the holding room were discharged within 24 hours (mean 11.8 hours).
  • No statistically significant difference in 28-day recurrence rates between holding room and hospitalized patients.
  • Holding room treatment was significantly less expensive ($526 vs $1439) than hospitalization for patients receiving short-term intravenous therapy.

Conclusions:

  • Holding room treatment is a medically effective alternative to hospitalization for selected children with status asthmaticus.
  • This approach offers significant economic benefits, reducing healthcare costs.
  • Holding room management represents an efficient and cost-effective strategy for pediatric asthma emergencies.

Related Concept Videos

Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...